Pathophysiology and diagnosis of obstruction in hypertrophic cardiomyopathy

Czech version

Authors: D. Zemánek
Authors‘ workplace: Kardiologická klinika 2. LF UK a FN v Motole, Praha
Published in: Kardiol Rev Int Med 2015, 17(1): 7-10
Category: Cardiology Review

Overview

Intraventricular obstruction is one of the fundamental pathophysiological manifestations of hypertrophic cardiomyopathy with significant clinical impact. Therefore, it is important to actively search for it during examination, even with the use of various provoking tests. In this article we would like to summarize current knowledge about its pathophysiology and diagnostic possibilities, including the use of provocative tests.

Keywords:
hypertrophic cardiomyopathy – obstruction – diagnosis – echocardiography

Sources

1. Maron MS, Olivotto I, Zenovich AG et al. Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction. Circulation 2006; 114: 2232– 2239.

2. Zemánek D, Tomašov P, Homolová S et al. Sublingual isosorbide dinitrate for the detection of obstruction in hypertrophic cardiomyopathy. Eur J Echocardiogr 2011; 12: 684– 687. doi: 10.1093/ ejechocard/ jer115.

3. Maron BJ, Maron MS, Wigle ED et al. The 50‑year history, controversy, and clinical implications of left ventricular outflow tract obstruction in hypertrophic cardiomyopathy from idiopathic hypertrophic subaortic stenosis to hypertrophic cardiomyopathy: from idiopathic hypertrophic subaortic stenosis to hypertrophic cardiomyopathy. J Am Coll Cardiol 2009; 54: 191– 200. doi: 10.1016/ j.jacc.2008.11.069.

4. Sherrid MV, Chaudhry FA, Swistel DG. Obstructive hypertrophic cardiomyopathy: echocardiography, pathophysiology, and the continuing evolution of surgery for obstruction. Ann Thorac Surg 2003; 75: 620– 632.

5. Martin R, Lairez O, Boudou N et al. Relation between left ventricular outflow tract obstruction and left ventricular shape in patients with hypertrophic cardiomyopathy: a cardiac magnetic resonance imaging study. Arch Cardiovasc Dis 2013; 106: 440– 447. doi: 10.1016/ j.acvd.2013.05.002.

6. Kizilbash AM, Heinle SK, Grayburn PA. Spontaneous variability of left ventricular outflow tract gradient in hypertrophic obstructive cardiomyopathy. Circulation 1998; 97: 461– 466.

7. Yu EH, Omran AS, Wigle ED et al. Mitral regurgitation in hypertrophic obstructive cardiomyopathy: relationship to obstruction and relief with myectomy. J Am Coll Cardiol 2000; 36: 19– 25.

8. Jensen MK, Havndrup O, Pecini R et al. Comparison of Valsalva manoeuvre and exercise in echocardiographic evaluation of left ventricular outflow tract obstruction in hypertrophic cardiomyopathy. Eur J Echocardiogr 2010; 11: 763– 769. doi: 10.1093/ ejechocard/ jeq063.

9. Braunwald F, Oldham HN, Ross J et al. Hemodynamic alterations in idiopathic hypertrophic subaortic stenosis induced by sympathomimetic drugs. Am J Cardiol 1962; 10: 489– 495.

10. Elesber A, Nishimura RA, Rihal CS et al. Utility of isoproterenol to provoke outflow tract gradients in patients with hypertrophic cardiomyopathy. Am J Cardiol 2008; 101: 516– 520. doi: 10.1016/ j.amjcard.2007.09.111.

11. Marwick TH, Nakatani S, Haluska B et al. Provocation of latent left ventricular outflow tract gradients with amyl nitrite and exercise in hypertrophic cardiomyopathy. Am J Cardiol 1995; 75: 805– 809.

12. Zemánek D, Tomašov P, Bělehrad M et al. Comparison of sublingual isosorbide dinitrate and Valsalva maneuver for the detection of obstruction in hypertrophic cardiomyopathy. Arch Med Sci 2015; [in press] doi: 10.5114/ aoms.2015.47096.

13. Lafitte S, Reant P, Touche C et al. Paradoxical response to exercise in asymptomatic hypertrophic cardiomyopathy: a new description of outflow tract obstruction dynamics. J Am Coll Cardiol 2013; 62: 842– 850. doi: 10.1016/ j.jacc.2013.06.007.

14. Dimitrow PP, Cotrim C, Cheng TO. The importance of upright posture in exercise testing and training for patients with hypertrophic cardiomyopathy. Eur J Prev Cardiol 2014; 108: 614.

15. Minami Y, Kajimoto K, Terajima Y et al. Clinical implications of midventricular obstruction in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 2011; 57: 2346– 2355. doi: 10.1016/ j.jacc.2011.02.033.

16. Maron MS, Finley JJ, Bos JM et al. Prevalence, clinical significance, and natural history of left ventricular apical aneurysms in hypertrophic cardiomyopathy. Circulation 2008; 118: 1541– 1549. doi: 10.1161/ CIRCULATIONAHA.108.781401.